COSMOS Pharmaceutical Corporation (CSMYF)

COSMOS Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is June - May.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Market Capitalization	3,738	4,854	3,199	3,758	3,756	5,508
Market Cap Growth	-2.50%	51.75%	-14.89%	0.05%	-31.81%	-3.16%
Enterprise Value	3,717	4,894	3,149	3,629	3,548	5,137
Last Close Price	48.27	46.06	49.16	49.16	-	-
PE Ratio	18.71	22.60	20.57	22.07	20.86	22.21
PS Ratio	0.56	0.69	0.52	0.63	0.64	0.83
PB Ratio	2.17	2.72	2.17	2.49	2.54	3.54
P/TBV Ratio	2.17	2.72	2.18	2.49	2.54	3.54
P/FCF Ratio	-	-	-	67.33	-	333.02
P/OCF Ratio	9.81	13.34	9.11	9.65	15.01	21.64
EV/Sales Ratio	0.55	0.70	0.51	0.61	0.60	0.77
EV/EBITDA Ratio	8.94	11.27	9.63	10.68	10.16	11.98
EV/EBIT Ratio	14.07	17.47	15.72	16.83	15.31	16.97
EV/FCF Ratio	-1256.53	-	-	65.02	-	310.54
Debt / Equity Ratio	0.15	0.19	0.15	0.09	0.05	0.06
Debt / EBITDA Ratio	0.63	0.80	0.66	0.38	0.21	0.22
Debt / FCF Ratio	-	-	-	2.33	-	5.77
Asset Turnover	2.03	2.02	2.15	2.11	2.15	2.20
Inventory Turnover	8.50	8.94	9.49	9.16	9.52	10.19
Quick Ratio	0.19	0.31	0.30	0.29	0.28	0.39
Current Ratio	0.72	0.75	0.72	0.71	0.71	0.78
Return on Equity (ROE)	12.17%	12.67%	11.05%	11.85%	12.83%	17.17%
Return on Assets (ROA)	4.95%	5.04%	4.39%	4.80%	5.29%	6.26%
Return on Invested Capital (ROIC)	11.46%	12.74%	11.52%	12.65%	14.47%	20.14%
Return on Capital Employed (ROCE)	13.00%	13.30%	12.00%	13.20%	14.80%	18.20%
Earnings Yield	5.34%	4.42%	4.86%	4.53%	4.79%	4.50%
FCF Yield	-0.08%	-0.12%	-0.13%	1.49%	-2.34%	0.30%
Dividend Yield	1.00%	1.05%	0.78%	0.73%	-	-
Payout Ratio	17.79%	16.01%	19.05%	13.72%	14.11%	8.38%
Buyback Yield / Dilution	-	-0.02%	-0.05%	0.00%	0.00%	0.00%
Total Shareholder Return	1.00%	1.03%	0.72%	0.73%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.